India ki pharma market mein ek naya trend dekhne ko mil raha hai. Diabetes aur weight-management ke liye istemal hone wali dawa Mounjaro ne desh ke doosre GLP-1 medicines ko peeche chhodte hue India ka top-selling GLP-1 brand ban gaya hai.
GLP-1 (Glucagon-Like Peptide-1) category ki dawaiyan blood sugar control karne ke saath-saath weight loss mein bhi madadgar maani jaati hain, jisse inki demand pichle kuch saalon mein tezi se badhi hai. Mounjaro ki popularity iska sabse bada udaharan hai.
Doctors ka kehna hai ki badalti lifestyle, junk food ki adat aur badhta obesity India mein diabetes ke cases ko lagatar badha raha hai, jisse aisi advanced dawaiyon ki maang bhi badh rahi hai. Shehri madhyam-varg mein khaas taur par is dawa ki demand dekhi ja rahi hai.
Halaanki, health experts yeh bhi chetavni dete hain ki aisi dawaiyan sirf doctor ki salah par hi lena chahiye, kyunki inke side-effects aur long-term asar ko lekar research abhi bhi jaari hai. Self-medication is category mein khatarnak ho sakta hai.
Pharma companies ke liye yeh growth ek bada business opportunity bhi hai, aur aane wale samay mein aur bhi naye GLP-1 products India ke market mein aane ki ummeed hai, jisse competition aur affordability dono behtar ho sakte hain.

